The brain reacting to COVID-19: analysis of the cerebrospinal fluid proteome, RNA and inflammation

[1]  E. Keller,et al.  Cerebrospinal fluid findings in COVID-19: a multicenter study of 150 lumbar punctures in 127 patients , 2022, Journal of neuroinflammation.

[2]  D. Perl,et al.  Mild respiratory SARS-CoV-2 infection can cause multi-lineage cellular dysregulation and myelin loss in the brain , 2022, bioRxiv.

[3]  I. Cobos,et al.  Dysregulation of brain and choroid plexus cell types in severe COVID-19 , 2021, Nature.

[4]  J. Saez-Rodriguez,et al.  Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T-cell interactions , 2021, Immunity.

[5]  D. Kell,et al.  Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin , 2021, Cardiovascular Diabetology.

[6]  Christoph B. Messner,et al.  Ultra-fast proteomics with Scanning SWATH , 2021, Nature Biotechnology.

[7]  Kathleen M. Jagodnik,et al.  Gene Set Knowledge Discovery with Enrichr , 2021, Current protocols.

[8]  K. Melmed,et al.  Cerebrospinal fluid in COVID-19: A systematic review of the literature , 2021, Journal of the Neurological Sciences.

[9]  K. Blennow,et al.  Biomarkers for central nervous system injury in cerebrospinal fluid are elevated in COVID‐19 and associated with neurological symptoms and disease severity , 2020, European journal of neurology.

[10]  C. Conrad,et al.  Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19 , 2020, Nature Neuroscience.

[11]  S. Kremer,et al.  Cerebrospinal fluid features in COVID-19 patients with neurologic manifestations: correlation with brain MRI findings in 58 patients , 2020, The Journal of infectious diseases.

[12]  J. Claassen,et al.  Cerebrospinal Analysis in Patients With COVID-19 , 2020, Open forum infectious diseases.

[13]  M. Aepfelbacher,et al.  Neuropathology of patients with COVID-19 in Germany: a post-mortem case series , 2020, The Lancet Neurology.

[14]  K. Mertz,et al.  Correlates of critical illness-related encephalopathy predominate postmortem COVID-19 neuropathology , 2020, Acta Neuropathologica.

[15]  H. Kamel,et al.  Effects of COVID-19 on the Nervous System , 2020, Cell.

[16]  B. Schraven,et al.  Serum and CSF cytokine levels mirror different neuroimmunological mechanisms in patients with LGI1 and Caspr2 encephalitis. , 2020, Cytokine.

[17]  B. Hemmer,et al.  Cerebrospinal fluid findings in COVID-19 patients with neurological symptoms , 2020, Journal of the Neurological Sciences.

[18]  Maria Thom,et al.  The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings , 2020, Brain : a journal of neurology.

[19]  T. Ueland,et al.  Increased interleukin-6 and macrophage chemoattractant protein-1 are associated with respiratory failure in COVID-19 , 2020, Scientific Reports.

[20]  Christoph B. Messner,et al.  Ultra-High-Throughput Clinical Proteomics Reveals Classifiers of COVID-19 Infection , 2020, Cell Systems.

[21]  S. Kremer,et al.  Neurologic Features in Severe SARS-CoV-2 Infection , 2020, The New England journal of medicine.

[22]  Wenzhong Liu,et al.  COVID-19:Attacks the 1-Beta Chain of Hemoglobin and Captures the Porphyrin to Inhibit Human Heme Metabolism , 2020 .

[23]  Florian P Bayer,et al.  Robust, reproducible and quantitative analysis of thousands of proteomes by micro-flow LC–MS/MS , 2020, Nature Communications.

[24]  Alex A Henneman,et al.  iq: an R package to estimate relative protein abundances from ion quantification in DIA-MS-based proteomics , 2020, Bioinform..

[25]  Sujata,et al.  A Prospective Study of Neurologic Disorders in Hospitalized COVID-19 Patients in New York City , 2020 .

[26]  Christoph B. Messner,et al.  DIA-NN: Neural networks and interference correction enable deep proteome coverage in high throughput , 2019, Nature Methods.

[27]  The UniProt Consortium,et al.  UniProt: a worldwide hub of protein knowledge , 2018, Nucleic Acids Res..

[28]  H. Heinze,et al.  Biomarkers of Neurodegeneration in Autoimmune-Mediated Encephalitis , 2018, Front. Neurol..

[29]  Babykumari P. Chitramuthu,et al.  Progranulin: a new avenue towards the understanding and treatment of neurodegenerative disease , 2017, Brain : a journal of neurology.

[30]  Param Priya Singh,et al.  Progranulin, lysosomal regulation and neurodegenerative disease , 2017, Nature Reviews Neuroscience.

[31]  M. Nishihara,et al.  Progranulin Protects Hippocampal Neurogenesis via Suppression of Neuroinflammatory Responses Under Acute Immune Stress , 2017, Molecular Neurobiology.

[32]  N. Pochet,et al.  Dissecting the role of non-coding RNAs in the accumulation of amyloid and tau neuropathologies in Alzheimer’s disease , 2016, bioRxiv.

[33]  C. Blauwendraat,et al.  Cerebrospinal Fluid Progranulin, but Not Serum Progranulin, Is Reduced in GRN-Negative Frontotemporal Dementia , 2016, Neurodegenerative Diseases.

[34]  C. Blauwendraat,et al.  Serum Levels of Progranulin Do Not Reflect Cerebrospinal Fluid Levels in Neurodegenerative Disease. , 2016, Current Alzheimer research.

[35]  J. Dalmau,et al.  The clinical spectrum of Caspr2 antibody–associated disease , 2016, Neurology.

[36]  J. Josse,et al.  missMDA: A Package for Handling Missing Values in Multivariate Data Analysis , 2016 .

[37]  H. Heinze,et al.  Progranulin levels in status epilepticus as a marker of neuronal recovery and neuroprotection , 2015, Epilepsy & Behavior.

[38]  Matthew E. Ritchie,et al.  limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.

[39]  H. Heinze,et al.  Progranulin and Amyloid-β Levels: Relationship to Neuropsychology in Frontotemporal and Alzheimer's Disease. , 2015, Journal of Alzheimer's disease : JAD.

[40]  Marco Y. Hein,et al.  Accurate Proteome-wide Label-free Quantification by Delayed Normalization and Maximal Peptide Ratio Extraction, Termed MaxLFQ * , 2014, Molecular & Cellular Proteomics.

[41]  R. Petersen,et al.  Progranulin protein levels are differently regulated in plasma and CSF , 2014, Neurology.

[42]  R. Balice-Gordon,et al.  Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study , 2014, The Lancet Neurology.

[43]  P. Damme,et al.  Cellular Effects of Progranulin in Health and Disease , 2011, Journal of Molecular Neuroscience.

[44]  Terry M. Therneau,et al.  Faster cyclic loess: normalizing RNA arrays via linear models , 2004, Bioinform..

[45]  Terence P. Speed,et al.  A comparison of normalization methods for high density oligonucleotide array data based on variance and bias , 2003, Bioinform..

[46]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[47]  A. Bateman,et al.  Cellular Localization of Gene Expression for Progranulin , 2000, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[48]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .